GlaxoSmithKline posts rising Q3 profits
British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profit rose seven percent, boosted by growth across its main pharmaceuticals, vaccines and consumer healthcare divisions.
The London-listed group also hiked its shareholder dividend by six percent to 17 pence, and added that it would increase share repurchases this year to £2.3 billion, compared with £2.0 billion previously.
Earnings after taxation increased to £1.378 billion ($2.20 billion, 1.58 billion euros) in the three months to the end of September, compared with £1.288 in the same part of last year, GSK said in a results statement.
Sales grew six percent to £6.992 billion in the reporting period.
"The breadth and mix of GSK's product and geographic portfolio is helping the group to mitigate economic volatility," chief executive Andrew Witty said in the earnings release.
"However, the environment for pharmaceutical and consumer products remains challenging."
In early afternoon deals, GSK's share price rose 0.47 percent to 1,388.50 pence on London's FTSE 100 index of leading companies, which was 0.23 percent higher at 5,538.16 points.
"GlaxoSmithkline's third quarter numbers may not be the most exciting, but the pharmaceutical giant continues to go from strength to strength," said ETX Capital senior trader Manoj Ladwa.
"Despite reporting in-line with analyst expectations, investors will be encouraged by the 6.0-percent hike in dividend and shifting the share buy-back programme up a notch."
The company was last year plagued by exceptional legal charges linked to its former diabetes drug Avandia, which has been pulled from European shelves on fears that it increased the risk of heart attack and strokes.
GSK was rocked in September 2010 when the European Union medicines regulator decided to ban Avandia. Regulators also restricted its availability in the United States.
The EU pulled Avandia owing to concerns over its active substance rosiglitazone. It decided also to halt the sale of Glaxo's other diabetes drugs, Avandamet and Avaglim, since they too contained rosiglitazone.
(c) 2011 AFP
-
GlaxoSmithKline reports return to profit in second quarter
Jul 26, 2011 |
not rated yet |
0
-
GSK to take $3.4 bln Avandia legal charge
Jan 17, 2011 |
not rated yet |
0
-
SAP profits up strongly in third quarter
Oct 14, 2011 |
not rated yet |
0
-
IBM raises guidance, beats Street estimates
Jul 18, 2011 |
not rated yet |
0
-
Drugs firm GSK eyes India acquisitions: chief executive
Oct 03, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
ACP issues recommendations for management of high blood glucose in hospitalized patients
High blood glucose is associated with poor outcomes in hospitalized patients, and use of intensive insulin therapy (IIT) to control hyperglycemia is a common practice in hospitals. But the recent evidence does not show a ...
Other
19 hours ago |
not rated yet |
0
Future doctors unaware of their obesity bias
Two out of five medical students have an unconscious bias against obese people, according to a new study by researchers at Wake Forest Baptist Medical Center. The study is published online ahead of print in the Journal of ...
Other
May 23, 2013 |
not rated yet |
0
Plastic realistic: Medical students to use plastinated human bodies for anatomy learning
Nanyang Technological University's (NTU) new medical school will be pioneering the use of plastinated bodies for medical education in Singapore.
Other
May 23, 2013 |
not rated yet |
0
Survey points out deficiencies in addictions training for medical residents
A 2012 survey of internal medicine residents at Massachusetts General Hospital (MGH) – one of the nation's leading teaching hospitals – found that more than half rated the training they had received in addiction and other ...
Other
May 22, 2013 |
5 / 5 (1) |
0
Early use of tracheostomy for mechanically ventilated patients not associated with improved survival
For critically ill patients receiving mechanical ventilation, early tracheostomy (within the first 4 days after admission) was not associated with an improvement in the risk of death within 30 days compared to patients who ...
Other
May 21, 2013 |
not rated yet |
0
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Pollen count apps for smartphones are nothing to sneeze at
Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.
Oct 26, 2011
Rank: not rated yet
Surely you must have something for amnesia?